Wow! awesome info thanks! This board really does have some amazing posters! I’m more excited about this company than any other in my life. It’s neat that the technology is for good rather than the usual corporate ravaging of the planet for profits. What do yo make of the extremely low volume? It’s the one thing (from a technical perspective) that seems off to me.
Linda Powers said something similar at the SMi 3rd Cancer Vaccines Conference in London in September 2014.
At the 9m42s mark:
If you are new to DCVax and NWBO, I recommend rewinding this presentation to the beginning and watching the entire video. It's probably the best introduction/overview to the DCVax platform that I've seen.
Wow. It began to dawn on me what they are trying to do. This first one which would take a long and winding road would not be repeated again. Because once this had been validated, that would be it. I thought it is just for DCVax-L but apparently for Direct too. If true, this is huge. I thought no one had been thinking about it. But few days ago I knew this. Thank you for sharing this idea. I now begin to see why LP would rather take the road less traveled. All imo.
The prospect of even a fraction of this promise coming to fruition is why I`m still here.
In addition to that hope, I also had two friends referred to Keyoumars and they told me directly of Keyoumars wonderful nature and sheer humanity, which we all then went on to witness first hand during his plea to unblind at ASCO two years ago.
However when it comes to our management I will never be convinced of anything other than the fact that yes we were dealt a bad hand but my god our management played it as badly as it could have been played.
Nice post... the only thing is, it is coming from LP.. when did She last time said anything that happend?? But anyway lets hope she have that one right.. what does “label extension” mean? Only P3 needed or maybe not even any trials ? Any one know?? BW
I love this idea, hyperopia, but I am thinking L and Direct are not exactly made in the same way, so I’m left wondering if LP may have meant something else when making this statement.
So we can treat with the same product, made the same way, all of these diverse cancers.
The process for making Direct is somewhat different, with the process for making Direct being partially automated.